- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/35 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Mycobacteriaceae (F)
Patent holdings for IPC class C07K 14/35
Total number of patents in this class: 580
10-year publication summary
|
49
|
35
|
29
|
29
|
35
|
27
|
34
|
42
|
27
|
31
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The UAB Research Foundation | 667 |
23 |
| Altor BioScience, LLC | 80 |
18 |
| International AIDS Vaccine Initiative, Inc. | 65 |
16 |
| University of Washington | 2464 |
16 |
| Longhorn Vaccines and Diagnostics, LLC | 90 |
13 |
| Revolo Biotherapeutics Limited | 31 |
13 |
| Glaxosmithkline Biologicals S.A. | 1602 |
12 |
| The Regents of the University of California | 20902 |
11 |
| Oxford NanoPore Technologies Limited | 264 |
11 |
| Wisconsin Alumni Research Foundation | 3903 |
9 |
| The General Hospital Corporation | 4890 |
9 |
| Qiagen Sciences, LLC | 192 |
9 |
| President and Fellows of Harvard College | 6115 |
8 |
| Glaxo Group Limited | 4347 |
7 |
| HAV Vaccines Limited | 10 |
7 |
| Illumina, Inc. | 3538 |
7 |
| Institut Pasteur | 778 |
6 |
| Oxford NanoPore Technologies plc | 397 |
6 |
| City of Hope | 1048 |
5 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 3303 |
5 |
| Other owners | 369 |